The Global Breast Cancer Liquid Biopsy Market Size was estimated at USD 122.78 million in 2023 and is projected to reach USD 321.47 million by 2029, exhibiting a CAGR of 17.40% during the forecast period.
Report Overview:
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
This report provides a deep insight into the global Breast Cancer Liquid Biopsy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Breast Cancer Liquid Biopsy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Breast Cancer Liquid Biopsy market in any manner.
Global Breast Cancer Liquid Biopsy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- QIAGEN
- Roche Diagnostics
- Bio-Rad Laboratories
- Myriad Genetics
- Menarini Silicon Biosystems
- Genomic Health
- Thermo Fisher Scientific
- Illumina
- Biocept
- Trovagene
- Guardant Health
- RainDance Technologies
- MDx Health
Market Segmentation (by Type)
- Circulating Tumor Cells (CTCs)
- Cell-Free DNA (CfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
Market Segmentation (by Application)
- Hospitals
- Diagnostic Centers
- Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Breast Cancer Liquid Biopsy Market
- Overview of the regional outlook of the Breast Cancer Liquid Biopsy Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Breast Cancer Liquid Biopsy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Breast Cancer Liquid Biopsy
1.2 Key Market Segments
1.2.1 Breast Cancer Liquid Biopsy Segment by Type
1.2.2 Breast Cancer Liquid Biopsy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Breast Cancer Liquid Biopsy Market Overview
2.1 Global Market Overview
2.1.1 Global Breast Cancer Liquid Biopsy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Breast Cancer Liquid Biopsy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Breast Cancer Liquid Biopsy Market Competitive Landscape
3.1 Global Breast Cancer Liquid Biopsy Sales by Manufacturers (2019-2024)
3.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Manufacturers (2019-2024)
3.3 Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Breast Cancer Liquid Biopsy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Breast Cancer Liquid Biopsy Sales Sites, Area Served, Product Type
3.6 Breast Cancer Liquid Biopsy Market Competitive Situation and Trends
3.6.1 Breast Cancer Liquid Biopsy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Breast Cancer Liquid Biopsy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Breast Cancer Liquid Biopsy Industry Chain Analysis
4.1 Breast Cancer Liquid Biopsy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Breast Cancer Liquid Biopsy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Breast Cancer Liquid Biopsy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Breast Cancer Liquid Biopsy Sales Market Share by Type (2019-2024)
6.3 Global Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
6.4 Global Breast Cancer Liquid Biopsy Price by Type (2019-2024)
7 Breast Cancer Liquid Biopsy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Breast Cancer Liquid Biopsy Market Sales by Application (2019-2024)
7.3 Global Breast Cancer Liquid Biopsy Market Size (M USD) by Application (2019-2024)
7.4 Global Breast Cancer Liquid Biopsy Sales Growth Rate by Application (2019-2024)
8 Breast Cancer Liquid Biopsy Market Segmentation by Region
8.1 Global Breast Cancer Liquid Biopsy Sales by Region
8.1.1 Global Breast Cancer Liquid Biopsy Sales by Region
8.1.2 Global Breast Cancer Liquid Biopsy Sales Market Share by Region
8.2 North America
8.2.1 North America Breast Cancer Liquid Biopsy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Breast Cancer Liquid Biopsy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Breast Cancer Liquid Biopsy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Breast Cancer Liquid Biopsy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Breast Cancer Liquid Biopsy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 QIAGEN
9.1.1 QIAGEN Breast Cancer Liquid Biopsy Basic Information
9.1.2 QIAGEN Breast Cancer Liquid Biopsy Product Overview
9.1.3 QIAGEN Breast Cancer Liquid Biopsy Product Market Performance
9.1.4 QIAGEN Business Overview
9.1.5 QIAGEN Breast Cancer Liquid Biopsy SWOT Analysis
9.1.6 QIAGEN Recent Developments
9.2 Roche Diagnostics
9.2.1 Roche Diagnostics Breast Cancer Liquid Biopsy Basic Information
9.2.2 Roche Diagnostics Breast Cancer Liquid Biopsy Product Overview
9.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Product Market Performance
9.2.4 Roche Diagnostics Business Overview
9.2.5 Roche Diagnostics Breast Cancer Liquid Biopsy SWOT Analysis
9.2.6 Roche Diagnostics Recent Developments
9.3 Bio-Rad Laboratories
9.3.1 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Basic Information
9.3.2 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Overview
9.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Market Performance
9.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy SWOT Analysis
9.3.5 Bio-Rad Laboratories Business Overview
9.3.6 Bio-Rad Laboratories Recent Developments
9.4 Myriad Genetics
9.4.1 Myriad Genetics Breast Cancer Liquid Biopsy Basic Information
9.4.2 Myriad Genetics Breast Cancer Liquid Biopsy Product Overview
9.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Product Market Performance
9.4.4 Myriad Genetics Business Overview
9.4.5 Myriad Genetics Recent Developments
9.5 Menarini Silicon Biosystems
9.5.1 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Basic Information
9.5.2 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Overview
9.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Market Performance
9.5.4 Menarini Silicon Biosystems Business Overview
9.5.5 Menarini Silicon Biosystems Recent Developments
9.6 Genomic Health
9.6.1 Genomic Health Breast Cancer Liquid Biopsy Basic Information
9.6.2 Genomic Health Breast Cancer Liquid Biopsy Product Overview
9.6.3 Genomic Health Breast Cancer Liquid Biopsy Product Market Performance
9.6.4 Genomic Health Business Overview
9.6.5 Genomic Health Recent Developments
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Basic Information
9.7.2 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Overview
9.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Market Performance
9.7.4 Thermo Fisher Scientific Business Overview
9.7.5 Thermo Fisher Scientific Recent Developments
9.8 Illumina
9.8.1 Illumina Breast Cancer Liquid Biopsy Basic Information
9.8.2 Illumina Breast Cancer Liquid Biopsy Product Overview
9.8.3 Illumina Breast Cancer Liquid Biopsy Product Market Performance
9.8.4 Illumina Business Overview
9.8.5 Illumina Recent Developments
9.9 Biocept
9.9.1 Biocept Breast Cancer Liquid Biopsy Basic Information
9.9.2 Biocept Breast Cancer Liquid Biopsy Product Overview
9.9.3 Biocept Breast Cancer Liquid Biopsy Product Market Performance
9.9.4 Biocept Business Overview
9.9.5 Biocept Recent Developments
9.10 Trovagene
9.10.1 Trovagene Breast Cancer Liquid Biopsy Basic Information
9.10.2 Trovagene Breast Cancer Liquid Biopsy Product Overview
9.10.3 Trovagene Breast Cancer Liquid Biopsy Product Market Performance
9.10.4 Trovagene Business Overview
9.10.5 Trovagene Recent Developments
9.11 Guardant Health
9.11.1 Guardant Health Breast Cancer Liquid Biopsy Basic Information
9.11.2 Guardant Health Breast Cancer Liquid Biopsy Product Overview
9.11.3 Guardant Health Breast Cancer Liquid Biopsy Product Market Performance
9.11.4 Guardant Health Business Overview
9.11.5 Guardant Health Recent Developments
9.12 RainDance Technologies
9.12.1 RainDance Technologies Breast Cancer Liquid Biopsy Basic Information
9.12.2 RainDance Technologies Breast Cancer Liquid Biopsy Product Overview
9.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Product Market Performance
9.12.4 RainDance Technologies Business Overview
9.12.5 RainDance Technologies Recent Developments
9.13 MDx Health
9.13.1 MDx Health Breast Cancer Liquid Biopsy Basic Information
9.13.2 MDx Health Breast Cancer Liquid Biopsy Product Overview
9.13.3 MDx Health Breast Cancer Liquid Biopsy Product Market Performance
9.13.4 MDx Health Business Overview
9.13.5 MDx Health Recent Developments
10 Breast Cancer Liquid Biopsy Market Forecast by Region
10.1 Global Breast Cancer Liquid Biopsy Market Size Forecast
10.2 Global Breast Cancer Liquid Biopsy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Breast Cancer Liquid Biopsy Market Size Forecast by Country
10.2.3 Asia Pacific Breast Cancer Liquid Biopsy Market Size Forecast by Region
10.2.4 South America Breast Cancer Liquid Biopsy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Breast Cancer Liquid Biopsy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Breast Cancer Liquid Biopsy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Breast Cancer Liquid Biopsy by Type (2025-2030)
11.1.2 Global Breast Cancer Liquid Biopsy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Breast Cancer Liquid Biopsy by Type (2025-2030)
11.2 Global Breast Cancer Liquid Biopsy Market Forecast by Application (2025-2030)
11.2.1 Global Breast Cancer Liquid Biopsy Sales (K Units) Forecast by Application
11.2.2 Global Breast Cancer Liquid Biopsy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Breast Cancer Liquid Biopsy Market Size Comparison by Region (M USD)
Table 5. Global Breast Cancer Liquid Biopsy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Breast Cancer Liquid Biopsy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Breast Cancer Liquid Biopsy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Breast Cancer Liquid Biopsy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2022)
Table 10. Global Market Breast Cancer Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Breast Cancer Liquid Biopsy Sales Sites and Area Served
Table 12. Manufacturers Breast Cancer Liquid Biopsy Product Type
Table 13. Global Breast Cancer Liquid Biopsy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Breast Cancer Liquid Biopsy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Breast Cancer Liquid Biopsy Market Challenges
Table 22. Global Breast Cancer Liquid Biopsy Sales by Type (K Units)
Table 23. Global Breast Cancer Liquid Biopsy Market Size by Type (M USD)
Table 24. Global Breast Cancer Liquid Biopsy Sales (K Units) by Type (2019-2024)
Table 25. Global Breast Cancer Liquid Biopsy Sales Market Share by Type (2019-2024)
Table 26. Global Breast Cancer Liquid Biopsy Market Size (M USD) by Type (2019-2024)
Table 27. Global Breast Cancer Liquid Biopsy Market Size Share by Type (2019-2024)
Table 28. Global Breast Cancer Liquid Biopsy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Breast Cancer Liquid Biopsy Sales (K Units) by Application
Table 30. Global Breast Cancer Liquid Biopsy Market Size by Application
Table 31. Global Breast Cancer Liquid Biopsy Sales by Application (2019-2024) & (K Units)
Table 32. Global Breast Cancer Liquid Biopsy Sales Market Share by Application (2019-2024)
Table 33. Global Breast Cancer Liquid Biopsy Sales by Application (2019-2024) & (M USD)
Table 34. Global Breast Cancer Liquid Biopsy Market Share by Application (2019-2024)
Table 35. Global Breast Cancer Liquid Biopsy Sales Growth Rate by Application (2019-2024)
Table 36. Global Breast Cancer Liquid Biopsy Sales by Region (2019-2024) & (K Units)
Table 37. Global Breast Cancer Liquid Biopsy Sales Market Share by Region (2019-2024)
Table 38. North America Breast Cancer Liquid Biopsy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Breast Cancer Liquid Biopsy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Breast Cancer Liquid Biopsy Sales by Region (2019-2024) & (K Units)
Table 41. South America Breast Cancer Liquid Biopsy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Breast Cancer Liquid Biopsy Sales by Region (2019-2024) & (K Units)
Table 43. QIAGEN Breast Cancer Liquid Biopsy Basic Information
Table 44. QIAGEN Breast Cancer Liquid Biopsy Product Overview
Table 45. QIAGEN Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. QIAGEN Business Overview
Table 47. QIAGEN Breast Cancer Liquid Biopsy SWOT Analysis
Table 48. QIAGEN Recent Developments
Table 49. Roche Diagnostics Breast Cancer Liquid Biopsy Basic Information
Table 50. Roche Diagnostics Breast Cancer Liquid Biopsy Product Overview
Table 51. Roche Diagnostics Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Roche Diagnostics Business Overview
Table 53. Roche Diagnostics Breast Cancer Liquid Biopsy SWOT Analysis
Table 54. Roche Diagnostics Recent Developments
Table 55. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Basic Information
Table 56. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Overview
Table 57. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bio-Rad Laboratories Breast Cancer Liquid Biopsy SWOT Analysis
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories Recent Developments
Table 61. Myriad Genetics Breast Cancer Liquid Biopsy Basic Information
Table 62. Myriad Genetics Breast Cancer Liquid Biopsy Product Overview
Table 63. Myriad Genetics Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Myriad Genetics Business Overview
Table 65. Myriad Genetics Recent Developments
Table 66. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Basic Information
Table 67. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Overview
Table 68. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Menarini Silicon Biosystems Business Overview
Table 70. Menarini Silicon Biosystems Recent Developments
Table 71. Genomic Health Breast Cancer Liquid Biopsy Basic Information
Table 72. Genomic Health Breast Cancer Liquid Biopsy Product Overview
Table 73. Genomic Health Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Genomic Health Business Overview
Table 75. Genomic Health Recent Developments
Table 76. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Basic Information
Table 77. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Overview
Table 78. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Recent Developments
Table 81. Illumina Breast Cancer Liquid Biopsy Basic Information
Table 82. Illumina Breast Cancer Liquid Biopsy Product Overview
Table 83. Illumina Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Illumina Business Overview
Table 85. Illumina Recent Developments
Table 86. Biocept Breast Cancer Liquid Biopsy Basic Information
Table 87. Biocept Breast Cancer Liquid Biopsy Product Overview
Table 88. Biocept Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Biocept Business Overview
Table 90. Biocept Recent Developments
Table 91. Trovagene Breast Cancer Liquid Biopsy Basic Information
Table 92. Trovagene Breast Cancer Liquid Biopsy Product Overview
Table 93. Trovagene Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Trovagene Business Overview
Table 95. Trovagene Recent Developments
Table 96. Guardant Health Breast Cancer Liquid Biopsy Basic Information
Table 97. Guardant Health Breast Cancer Liquid Biopsy Product Overview
Table 98. Guardant Health Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Guardant Health Business Overview
Table 100. Guardant Health Recent Developments
Table 101. RainDance Technologies Breast Cancer Liquid Biopsy Basic Information
Table 102. RainDance Technologies Breast Cancer Liquid Biopsy Product Overview
Table 103. RainDance Technologies Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. RainDance Technologies Business Overview
Table 105. RainDance Technologies Recent Developments
Table 106. MDx Health Breast Cancer Liquid Biopsy Basic Information
Table 107. MDx Health Breast Cancer Liquid Biopsy Product Overview
Table 108. MDx Health Breast Cancer Liquid Biopsy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. MDx Health Business Overview
Table 110. MDx Health Recent Developments
Table 111. Global Breast Cancer Liquid Biopsy Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Breast Cancer Liquid Biopsy Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Breast Cancer Liquid Biopsy Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Breast Cancer Liquid Biopsy Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Breast Cancer Liquid Biopsy Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Breast Cancer Liquid Biopsy Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Breast Cancer Liquid Biopsy Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Breast Cancer Liquid Biopsy Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Breast Cancer Liquid Biopsy Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Breast Cancer Liquid Biopsy Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Breast Cancer Liquid Biopsy Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Breast Cancer Liquid Biopsy Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Breast Cancer Liquid Biopsy Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Breast Cancer Liquid Biopsy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Breast Cancer Liquid Biopsy Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Breast Cancer Liquid Biopsy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Breast Cancer Liquid Biopsy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Breast Cancer Liquid Biopsy Market Size (M USD), 2019-2030
Figure 5. Global Breast Cancer Liquid Biopsy Market Size (M USD) (2019-2030)
Figure 6. Global Breast Cancer Liquid Biopsy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Breast Cancer Liquid Biopsy Market Size by Country (M USD)
Figure 11. Breast Cancer Liquid Biopsy Sales Share by Manufacturers in 2023
Figure 12. Global Breast Cancer Liquid Biopsy Revenue Share by Manufacturers in 2023
Figure 13. Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Breast Cancer Liquid Biopsy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Breast Cancer Liquid Biopsy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Breast Cancer Liquid Biopsy Market Share by Type
Figure 18. Sales Market Share of Breast Cancer Liquid Biopsy by Type (2019-2024)
Figure 19. Sales Market Share of Breast Cancer Liquid Biopsy by Type in 2023
Figure 20. Market Size Share of Breast Cancer Liquid Biopsy by Type (2019-2024)
Figure 21. Market Size Market Share of Breast Cancer Liquid Biopsy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Breast Cancer Liquid Biopsy Market Share by Application
Figure 24. Global Breast Cancer Liquid Biopsy Sales Market Share by Application (2019-2024)
Figure 25. Global Breast Cancer Liquid Biopsy Sales Market Share by Application in 2023
Figure 26. Global Breast Cancer Liquid Biopsy Market Share by Application (2019-2024)
Figure 27. Global Breast Cancer Liquid Biopsy Market Share by Application in 2023
Figure 28. Global Breast Cancer Liquid Biopsy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Breast Cancer Liquid Biopsy Sales Market Share by Region (2019-2024)
Figure 30. North America Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Breast Cancer Liquid Biopsy Sales Market Share by Country in 2023
Figure 32. U.S. Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Breast Cancer Liquid Biopsy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Breast Cancer Liquid Biopsy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Breast Cancer Liquid Biopsy Sales Market Share by Country in 2023
Figure 37. Germany Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Breast Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Breast Cancer Liquid Biopsy Sales Market Share by Region in 2023
Figure 44. China Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Breast Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 50. South America Breast Cancer Liquid Biopsy Sales Market Share by Country in 2023
Figure 51. Brazil Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Breast Cancer Liquid Biopsy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Breast Cancer Liquid Biopsy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Breast Cancer Liquid Biopsy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Breast Cancer Liquid Biopsy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Breast Cancer Liquid Biopsy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Breast Cancer Liquid Biopsy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Breast Cancer Liquid Biopsy Market Share Forecast by Type (2025-2030)
Figure 65. Global Breast Cancer Liquid Biopsy Sales Forecast by Application (2025-2030)
Figure 66. Global Breast Cancer Liquid Biopsy Market Share Forecast by Application (2025-2030)
